• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT SRL ALINIQ AMS; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT SRL ALINIQ AMS; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE Back to Search Results
Catalog Number 03R89-20
Device Problem Computer System Security Problem (2899)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/23/2022
Event Type  malfunction  
Manufacturer Narrative
Catalog no; unique identifier (udi #): ams 2.06; catalog no 03r89-01; udi- n/a.Ams 2.07 (including patches)/alinity iq ams 2.07.2; catalog no 03r89-20; udi- n/a.Aliniq ams 2.08 (including patches); catalog no 03r89-21; udi- (b)(4).Aliniq ams 2.09; catalog no 03r89-23; udi- (b)(4).Aliniq ams 2.10; catalog no 03r89-24; udi- (b)(4).Aliniq ams 2.11; catalog no 03r89-47; udi- (b)(4).Aliniq ams 2.12; catalog no 03r89-48; udi- (b)(4).Abbottlink has no ln or sn.The investigation into this issue found that this vulnerability impacts all marketed versions of aliniq ams and abbottlink.The investigation also identified that the vulnerability can only be exploited on ams-abbottlink systems within customer networks with poor network security (labs with no firewall, or an poorly configured firewall).A product correction letter has been issued to all customers where both abbottlink and aliniq ams are installed.The product correction letter notifies customers of the issue and provides the necessary actions to be taken to reduce the risk of exploitation of this vulnerability until they are contacted by their abbott representative to schedule the mandatory installation of the new version of abbottlink once it is available.
 
Event Description
Abbott received a security vulnerability notification from ptc, the supplier who provides the software used in abbottlink, which resides on a customer-owned server.Within the overall software, the axeda desktop server is used to enable remote screen sharing through an abbottlink connection.The identified vulnerability could allow control of the operating system of the server where the software is installed.This vulnerability only impacts customer sites where both aliniq ams and the abbottlink axeda desktop server are installed when: the attacker has credentialled access to the customer network.The attacker knows the abbott-controlled axeda desktop server password; the attacker can connect to a specific port on the axeda desktop server.If the axeda vulnerability is exploited, the attacker could gain access through the axeda desktop server to aliniq ams services which has the potential for a delay in patient results, incorrect results, and/or data privacy issues.There have been no known exploits of this vulnerability on the aliniq ams.
 
Manufacturer Narrative
This emdr is being submitted as the attachment a (indicated in section d4- serial no) was inadvertently not attached to the initial emdr submission.Attachment a has now been attached to this submission.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINIQ AMS
Type of Device
CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT SRL
via giorgio ribotta 9
rome 00144
IT  00144
Manufacturer (Section G)
ABBOTT SRL
via giorgio ribotta 9
rome 00144
IT   00144
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key13981119
MDR Text Key298234785
Report Number3004032053-2022-00001
Device Sequence Number1
Product Code JQP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Remedial Action Notification
Type of Report Initial,Followup
Report Date 04/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03R89-20
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 03/15/2022
Initial Date FDA Received04/01/2022
Supplement Dates Manufacturer Received04/04/2022
Supplement Dates FDA Received04/07/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/01/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
Treatment
ABBOTTLINK 5.10; ABBOTTLINK 5.10
-
-